Crossmark

Thirty years of NRF2: advances and therapeutic challenges

Crossref DOI link: https://doi.org/10.1038/s41573-025-01145-0

Published Online: 2025-03-04

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Donna D. https://orcid.org/0000-0002-8972-697X
License Information

Text and Data Mining valid from 2025-03-04

Version of Record valid from 2025-03-04
More Information

Article History

Accepted: 23 January 2025

First Online: 4 March 2025

Competing interests

: The author declares no competing interests.